Brand Name
Adasuve
Generic Name
Loxapine
View Brand Information FDA approval date: June 15, 1988
Form: Aerosol, Capsule
What is Adasuve (Loxapine)?
ADASUVE is indicated for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. ADASUVE is an atypical antipsychotic indicated for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults . Limitations of Use: ADASUVE must be administered only in a certified healthcare setting . Limitations of Use: As part of the ADASUVE REMS Program to mitigate the risk of bronchospasm, ADASUVE must be administered only in a certified healthcare setting [see Warnings and Precautions.
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment